FdaApplication
NDA 020272
Identifiers
- fda_app_no: NDA020272
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1993-12-29 |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISPERDAL | RISPERIDONE | 2MG | TABLET;ORAL |
| RISPERDAL | RISPERIDONE | 0.25MG | TABLET;ORAL |
| RISPERDAL | RISPERIDONE | 5MG | TABLET;ORAL |
| RISPERDAL | RISPERIDONE | 1MG | TABLET;ORAL |
| RISPERDAL | RISPERIDONE | 3MG | TABLET;ORAL |
| RISPERDAL | RISPERIDONE | 0.5MG | TABLET;ORAL |
| RISPERDAL | RISPERIDONE | 4MG | TABLET;ORAL |
7 products